Integrity Advisory Solutions »

Fs Global Cr Opportunitie Fda shares owned by Integrity Advisory Solutions

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Integrity Advisory Solutions from 13F filings

Historical chart of Integrity Advisory Solutions investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Integrity Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Integrity Advisory Solutions

Quarter filed Position value Share count Share price at filing
2025-12-31 $101k 16k 6.30

More positions owned by Integrity Advisory Solutions

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Global Cr Etf (DGCB)
Dimensional Etf Trust Global Core Plus (DFGP)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Spdr Series Trust State Street Spd (SPMD)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Short Duration F (DFSD)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust State Street Spd (SPYM)

View all positions for Integrity Advisory Solutions

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Cetera Investment Advisers
Sit Investment Associates
LPL Financial
Vista Finance
Blackstone Group
Rockefeller Capital Management
Advisor Group Holdings
Summit Financial
Envestnet Asset Management
Thomas J. Herzfeld Advisors
Deschutes Portfolio Strategy
Ellis Investment Partners
Advisors Asset Management

View all funds holding Fs Global Cr Opportunitie Fda